High Incidence of Hyper-Vascular Liver Tumors Will Propel the Uptake of Radioembolization in USA
Why Buy This Report
- First-ever syndicated report with robust insights from Interventional Radiologists
- Helps in understanding the current market scenario of tumor embolization in the USA.
- Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model
- Valuable insights from from demand side of the market
- Keep up with the latest market trends and novel technologies
- Identify key players, local players and emerging players in the market
Table of Contents
RESEARCH PROCESS OVERVIEW
TUMOR EMBOLIZATION (TE) USA MARKET OVERVIEW
I - HEALTHCARE INFRASTRUCTURE (PROVIDER)
II - PROCEDURE INSIGHTS
III - BRAND PERCEPTION
IV - COMPETITIVE INTELLIGENCE
V - HEALTHCARE POLICY (PAYER)
VI - CLINICAL INTELLIGENCE (PHYSICIAN)
CONCLUSION
Companies Mentioned
- Merit Medical
- Boston Scientific
- Terumo
- BTG
